SPRB Valuation

Spruce Biosciences Inc

Add to Watchlist

Advanced Chart

0.133

+0.003(+2.310%)

Overview
Forecast
Valuation

SPRB Relative Valuation

SPRB's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, SPRB is overvalued; if below, it's undervalued.

Historical Valuation

Spruce Biosciences Inc (SPRB) is now in the Undervalued zone, suggesting that its current forward PS ratio of 0.00 is considered Undervalued compared with the five-year average of -67.52. The fair price of Spruce Biosciences Inc (SPRB) is between +Inf to +Inf according to relative valuation methord. Compared to the current price of 0.13 USD , Spruce Biosciences Inc is Undervalued By Fair.

Relative Value

Fair Zone

+Inf-+Inf

Current Price：0.13

Fair

Undervalued

Trailing

Forward

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

0.19

P/B

Median3y

0.65

Median5y

0.88

-1093.38

FCF Yield

Median3y

-136.13

Median5y

-98.87

Competitors Valuation Multiple

The average P/S ratio for SPRB's competitors is 0.76, providing a benchmark for relative valuation. Spruce Biosciences Inc Corp (SPRB) exhibits a P/S ratio of 0.00, which is -100.00% above the industry average. Given its robust revenue growth of -75.86%, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap

SPRB.O

Spruce Biosciences Inc

Loss

Average P/S: 0.76

-75.86%